Sustained Delivery of Nitric Oxide from Poly(ethylene glycol) Hydrogels Enhances Endothelialization in a Rat Carotid Balloon Injury Model

Cardiovascular Engineering and Technology

Volumn 2, Issue 2, 2011, Pages 113-123

  Taite, Lakeshia J ^a   West, Jennifer L ^b  

^a Georgia Institute of Technology   (United States)

^b Rice University   (United States)

Author keywords

Diazeniumdiolate; Endothelialization; Hydrogel; Nitric oxide; Poly(ethylene glycol)

Indexed keywords

ANIMAL MODEL; BALLOON INJURY; CAROTID ARTERY; DIAZENIUMDIOLATES; ENDOTHELIALIZATION; HIGH INCIDENCE; IN-VIVO; INTERVENTIONAL; INTIMAL HYPERPLASIA; INTIMAL THICKENINGS; OUTER SURFACE; PEG HYDROGEL; POLY(ETHYLENE GLYCOL) HYDROGEL; RESTENOSIS; VASCULAR DISEASE; VASCULAR PROSTHESIS;

CYTOLOGY; DISEASE CONTROL; ENDOTHELIAL CELLS; ETHYLENE; ETHYLENE GLYCOL; LEAD OXIDE; NITRIC OXIDE; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES;

HYDROGELS;

MACROGOL; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY; CELL MIGRATION; CELL PROLIFERATION; CELL REGENERATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ENDOTHELIUM CELL; HYDROGEL; MALE; NONHUMAN; RAT; RESTENOSIS; SUSTAINED DRUG RELEASE; THROMBOCYTE ADHESION;

EID: 79955843818     PISSN: 1869408X     EISSN: 18694098     Source Type: Journal    
DOI: 10.1007/s13239-011-0040-z     Document Type: Article

References (32)

1. Agata, J., J. J. Zhang, J. Chao, and L. Chao. Adrenomedullin gene delivery inhibits neointima formation in rat artery after balloon angioplasty. Regul. Pept. 112: 115-120, 2003.
2. Bailey, S. R. Local drug delivery: current applications. Prog. Cardiovasc. Dis. 40: 183-204, 1997.
3. Bauters, C., and J. M. Isner. The biology of restenosis. Prog. Cardiovasc. Dis. 40(2): 107-116, 1997.
4. Bohl, K. S., and J. L. West. Nitric oxide-generating polymers reduce platelet adhesion and smooth muscle cell proliferation. Biomaterials 21: 2273-2278, 2000.
5. Bult, H. Restenosis: a challenge for pharmacology. Trends Pharmacol. Sci. 21(7): 274-279, 2000.
6. Dangas, G. D., B. E. Claessen, A. Caixeta, E. A. Sanidas, G. S. Mintz, and R. Mehran. In-stent restenosis in the drug-eluting stent era. J. Am. Coll. Cardiol. 56: 1897-1907, 2010.
7. Elkins, C. J., J. M. Waugh, P. G. Amabile, H. Minamiguchi, M. Uy, K. Sugimoto, et al. Development of a platform to evaluate and limit in-stent restenosis. Tissue Eng. 8: 395-407, 2002.
8. Ettenson, D. S., and E. R. Edelman. Local drug delivery: an emerging approach in the treatment of restenosis. Vasc. Med. 5: 97-102, 2000.
9. Fattori, R., and T. Piva. Drug-eluting stents in vascular intervention. Lancet 361: 247-249, 2003.
10. Folts, J. D., and J. Loscalzo. Coating arterial and blood-contacting surfaces with NO-donating materials. In: Nitric Oxide and the Cardiovascular System, edited by J. Loscalzo, and J. A. Vita. Totowa, NJ: Humana Press, 2000, pp. 503-514.
11. Herrmann, R., G. Schmidmaier, B. Markl, A. Resch, I. Hahnel, A. Stemberger, et al. Antithrombogenic coating of stents using a biodegradable drug delivery technology. Thromb. Haemost. 82: 51-57, 1999.
12. Hrabie, J. A., J. R. Klose, D. A. Wink, and L. K. Keefer. New nitric oxide-releasing zwitterions derived from polyamines. J. Org. Chem. 58: 1472-1476, 1993.
13. Jun, H. W., L. J. Taite, and J. L. West. Nitric oxide-producing polyurethanes. Biomacromolecules 6: 838-844, 2005.
14. Kapadia, M. R., L. W. Chow, N. D. Tsihlis, S. S. Ahanchi, J. W. Eng, J. Murar, et al. Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia. J. Vasc. Surg. 47: 173-182, 2008.
15. Kavanagh, C. A., Y. A. Rochev, W. M. Gallagher, K. A. Dawson, and A. K. Keenan. Local drug delivery in restenosis injury: thermoresponsive co-polymers as potential drug delivery systems. Pharmacol. Ther. 102: 1-15, 2004.
16. Keefer, L. K. Progress toward clinical application of the nitric oxide-releasing diazeniumdiolates. Annu. Rev. Pharmacol. Toxicol. 43: 585-607, 2003.
17. Kelm, M. Nitric oxide metabolism and breakdown. Biochim. Biophys. Acta 1411: 273-289, 1999.
18. Lee, M. S., E. M. David, R. R. Makkar, and J. R. Wilentz. Molecular and cellular basis of restenosis after percutaneous coronary intervention: the intertwining roles of platelets, leukocytes, and the coagulation-fibrinolysis system. J. Pathol. 203: 861-870, 2004.
19. Lipke, E. A., and J. L. West. Localized delivery of nitric oxide from hydrogels inhibits neointima formation in a rat carotid balloon injury model. Acta Biomater. 1(6): 597-606, 2005.
20. Majesky, M. W., C. M. Giachelli, M. A. Reidy, and S. M. Schwartz. Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated mRNA phenotype during repair of arterial injury. Circ. Res. 71: 759-768, 1992.
21. Masters, K. S., E. A. Lipke, E. E. Rice, M. S. Liel, H. A. Myler, C. Zygourakis, et al. Nitric oxide-generating hydrogels inhibit neointima formation. J. Biomater. Sci. Polym. Ed. 16: 659-672, 2005.
22. Moore, S. Amino acid analysis: aqueous dimethyl sulfoxide as solvent for the ninhydrin reaction. J. Biol. Chem. 243: 6281-6283, 1968.
23. Pearce, C. G., S. F. Najjar, M. R. Kapadia, J. Murar, J. Eng, B. Lyle, et al. Beneficial effect of a short-acting NO donor for the prevention of neointimal hyperplasia. Free Radic. Biol. Med. 44: 73-81, 2008.
24. Raman, V. K., and E. R. Edelman. Coated stents: local pharmacology. Semin. Interv. Cardiol. 3: 133-137, 1998.
25. Saavedra, J. E., D. L. Mooradian, K. A. Mowery, M. H. Schoenfisch, M. L. Citro, K. M. Davies, et al. Conversion of a polysaccharide to nitric oxide-releasing form. Dual-mechanism anticoagulant activity of diazeniumdiolated heparin. Bioorg. Med. Chem. Lett. 10(8): 751-753, 2000.
26. Sharma, S., C. Christopoulos, N. Kukreja, and D. A. Gorog. Local drug delivery for percutaneous coronary intervention. Pharmacol. Ther. 2010.
27. Taite, L. J., P. Yang, H. W. Jun, and J. L. West. Nitric oxide-releasing polyurethane-PEG copolymer containing the YIGSR peptide promotes endothelialization with decreased platelet adhesion. J. Biomed. Mater. Res. B Appl. Biomater. 84(1): 108-116, 2008.
28. Takamiya, Y., S. I. Miura, Y. Tsuchiya, Y. Fukuda, B. Zhang, T. Kuwano, et al. Angiographic late lumen loss at the site of overlap of multiple Cypher sirolimus-eluting stents: ALSOCE study. J. Cardiol. 2010.
29. Tanabe, K., E. Regar, C. H. Lee, A. Hoye, W. J. van der Giessen, and P. W. Serruys. Local drug delivery using coated stents: new developments and future perspectives. Curr. Pharm. Des. 10: 357-367, 2004.
30. Virmani, R., F. D. Kolodgie, A. Farb, and A. Lafont. Drug eluting stents: are human and animal studies comparable? Heart 89: 133-138, 2003.
31. Walter, D. H., M. Cejna, L. Diaz-Sandoval, S. Willis, L. Kirkwood, P. W. Stratford, et al. Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis. Circulation 110: 36-45, 2004.
32. West, J. L., and J. A. Hubbell. Separation of the arterial wall from blood contact using hydrogel barriers reduces intimal thickening after balloon injury in the rat: the roles of medial and luminal factors in arterial healing. Proc. Natl Acad. Sci. U. S. A. 93: 13188-13193, 1996.